EHN is involved in several ongoing EU-funded research projects as a patient representative partner in each consortium. EHN’s primary role is to bring the patient perspective to the design and development of each project and to facilitate active and structured patient engagement in each project.
AIDAVA is a four-year project mainly funded by the Horizon Europe programme coordinated by the Universiteit Maastricht.
HYPERMARKER is a four-year international research project that received a 10 million euro grant from Horizon Europe and UK Research and Innovation.
AI4HF is a 4-year Horizon Europe project that aims to co-design, develop, evaluate and exploit an integrative and trustworthy artificial intelligence (AI) solution for personalised heart failure (HF) risk assessment.
Network for implementing multiomics approaches in atherosclerotic cardiovascular disease prevention and research, or AtheroNET, is a 4-year COST Action project which aims to connect experts from different fields that will focus on the use of multiple omics technologies anddata integration through machine learning/artificial intelligence to bring novel paradigms in atherosclerotic cardiovascular disease care.